AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Experiencing Month Over Month Prescription Growth For Asthma Drugs

A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Reply New Message

Prev Message Back To Forum Threaded View Next Message

AGORACOM-KE

Rank: Administrator [?]

Points: 8960 [?]

Votes: 2 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Experiencing Month Over Month Prescription Growth For Asthma Drugs

posted on Mar 21, 2022 11:20AM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply